About Pudee

Reliability, Responsibility and Rapidity

Founded in 2007, focus on the synthesis of small molecule compounds and the extraction of some natural compounds. We develop, produce and sell high-quality advanced intermediates and some APIs with competitive prices.
Get Appointment

Contact Info

  • Building 2, Handa Science and Technology Park
    No. 8 Pioneer Road
    High-tech Zone. Suzhou.
  • 86 512 6803 2792
    86 512 6803 2791
  • willdyhan@pudeepharm.com
    sales@pudeepharm.com

Product List

Difluoromethylthioacetic acid
Difluoromethylthioacetic acid | 83494-32-0
Flomoxef is a broad-spectrum cephalosporin oxygen ene (oxa cephalosporin) antibiotic, the β-lactamase is very stable, Difluoromethylthioacetic acid ……
1-Hydroxyethyl-1H-tetrazole-5-thiol
1-Hydroxyethyl-1H-tetrazole-5-thiol | 56610-81-2
Flomoxef is a broad-spectrum cephalosporin oxygen ene (oxa cephalosporin) antibiotic, the β-lactamase is very stable, 2-(5-Mercaptotetrazole-1-yl)et……
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid eth…… | 641569-96-2
Nilotinib is for treating of leukemia resistant to imatinib. 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate is a key inter……
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]ben…… | 641569-94-0
Nilotinib is for treating of leukemia resistant to imatinib. 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid is a key intermediate of ……
Nilotinib Intermediate
Nilotinib Intermediate | 641571-11-1
Nilotinib is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. it was develo……
(1s,2s,3R,5S) – (+) pinanediol
(1s,2s,3R,5S) – (+) pinanediol | 18680-27-8
Bortezomib is for treating relapsed multiple myeloma and mantle cell lymphoma. (1s,2s,3R,5S) – (+) pinanediol is a key intermediate of Bortezomibe.……
Bortezomib Intermediate
Bortezomib Intermediate | 179324-87-9
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma a……
(R)-Boroleu-(+)-pinanediol hydrochloride
(R)-Boroleu-(+)-pinanediol hydrochloride | 779357-85-6
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma a……
1-N-Boc-pyrrolidin-2-ylboronic acid
1-N-Boc-pyrrolidin-2-ylboronic acid | 149682-75-7
It is the intermediate of Bortezomib CAS: 179324-69-7. white crystalline powder. Purity 99% +, The minimum order quantity is 50 g.  Packing size : 1……